Healthinvest Partners Ab Cut Ligand Pharmaceuticals (LGND) Position; Pembina Pipeline (PBA) Covered By 3 Bullish Analysts Last Week

January 14, 2018 - By Adrian Mccoy

Among 5 analysts covering Pembina Pipeline (NYSE:PBA), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Pembina Pipeline had 8 analyst reports since August 10, 2015 according to SRatingsIntel. ational Bank Financial downgraded the stock to “Sector Perform” rating in Monday, July 18 report. The firm earned “Overweight” rating on Thursday, October 13 by JP Morgan. Credit Suisse downgraded the shares of PBA in report on Monday, June 20 to “Neutral” rating. On Friday, December 11 the stock rating was upgraded by Credit Suisse to “Outperform”. The company was upgraded on Monday, November 7 by GMP Securities. The stock has “Outperform” rating by RBC Capital Markets on Monday, August 10. RBC Capital Markets maintained the shares of PBA in report on Monday, November 9 with “Outperform” rating. See Pembina Pipeline Corporation (NYSE:PBA) latest ratings:

Healthinvest Partners Ab decreased Ligand Pharmaceuticals Inc (LGND) stake by 14.77% reported in 2017Q3 SEC filing. Healthinvest Partners Ab sold 8,300 shares as Ligand Pharmaceuticals Inc (LGND)’s stock rose 7.66%. The Healthinvest Partners Ab holds 47,900 shares with $6.52 million value, down from 56,200 last quarter. Ligand Pharmaceuticals Inc now has $3.14 billion valuation. The stock increased 0.64% or $0.95 during the last trading session, reaching $148.9. About 166,403 shares traded. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has declined 2.87% since January 14, 2017 and is downtrending. It has underperformed by 19.57% the S&P500.

The stock increased 0.23% or $0.08 during the last trading session, reaching $35.43. About 455,173 shares traded. Pembina Pipeline Corporation (NYSE:PBA) has risen 15.45% since January 14, 2017 and is uptrending. It has underperformed by 1.25% the S&P500.

Pembina Pipeline Corporation provides transportation and midstream services for the energy industry in North America. The company has market cap of $17.53 billion. It operates through four divisions: Conventional Pipelines, Oil Sands & Heavy Oil, Gas Services, and Midstream. It has a 35.86 P/E ratio. The Conventional Pipelines segment operates approximately 10,000 kilometers of pipeline network that transports hydrocarbon products and extends across Alberta and parts of British Columbia, Saskatchewan, and North Dakota.

Analysts await Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) to report earnings on February, 22. They expect $0.92 EPS, up 713.33% or $1.07 from last year’s $-0.15 per share. LGND’s profit will be $19.42M for 40.46 P/E if the $0.92 EPS becomes a reality. After $0.55 actual EPS reported by Ligand Pharmaceuticals Incorporated for the previous quarter, Wall Street now forecasts 67.27% EPS growth.

Investors sentiment increased to 1.69 in 2017 Q3. Its up 0.45, from 1.24 in 2017Q2. It increased, as 19 investors sold LGND shares while 68 reduced holdings. 50 funds opened positions while 97 raised stakes. 22.76 million shares or 0.86% more from 22.57 million shares in 2017Q2 were reported. Metropolitan Life Insurance Com Ny reported 0.01% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Opus Point Prns Ltd Liability Com has 0.19% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Da Davidson & has 0.01% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Knott David M accumulated 46.45% or 798,100 shares. 15,429 are held by Manufacturers Life Ins Communications The. Castleark Management Limited Liability Company has invested 0.43% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Royal Bancorporation Of Canada stated it has 98,151 shares. State Street Corporation has 0.01% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) for 852,417 shares. Keybank Natl Association Oh reported 0% stake. 4,474 are held by Hightower Ltd Liability Company. Nordea Invest Mngmt Ab holds 0.01% or 17,249 shares. 7,850 were accumulated by Aqr Management Limited. Port Solutions Limited Liability Company reported 0% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Timpani Mngmt Ltd Com invested in 1.74% or 35,124 shares. Guggenheim Cap Ltd Liability Company invested in 0.01% or 39,243 shares.

Since August 8, 2017, it had 0 insider purchases, and 6 insider sales for $4.86 million activity. FOEHR MATTHEW W sold $777,824 worth of stock. $685,375 worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) was sold by HIGGINS JOHN L. The insider Aryeh Jason sold $255,980. Sabba Stephen L sold $126,956 worth of stock or 925 shares. 18,625 shares were sold by Berkman Charles S, worth $2.36 million on Wednesday, August 9.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News